U.S. Markets closed
  • S&P Futures

    4,131.75
    -1.00 (-0.02%)
     
  • Dow Futures

    33,534.00
    -36.00 (-0.11%)
     
  • Nasdaq Futures

    13,967.00
    -8.75 (-0.06%)
     
  • Russell 2000 Futures

    2,223.90
    -1.00 (-0.04%)
     
  • Crude Oil

    60.62
    +0.44 (+0.73%)
     
  • Gold

    1,745.20
    -2.40 (-0.14%)
     
  • Silver

    25.48
    +0.05 (+0.21%)
     
  • EUR/USD

    1.1962
    +0.0007 (+0.0598%)
     
  • 10-Yr Bond

    1.6230
    -0.0520 (-3.10%)
     
  • Vix

    16.65
    -0.26 (-1.54%)
     
  • GBP/USD

    1.3764
    +0.0012 (+0.0881%)
     
  • USD/JPY

    108.8400
    -0.2080 (-0.1907%)
     
  • BTC-USD

    63,172.13
    +2,534.22 (+4.18%)
     
  • CMC Crypto 200

    1,360.65
    +66.66 (+5.15%)
     
  • FTSE 100

    6,890.49
    +1.37 (+0.02%)
     
  • Nikkei 225

    29,649.85
    -101.76 (-0.34%)
     

Lawsuits Filed Against SWI, XOM and ATNX - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / March 5, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

SolarWinds Corporation (NYSE:SWI)

CONTACT JAKUBOWITZ ABOUT SWI:
https://claimyourloss.com/securities/solarwinds-corporation-loss-submission-form/?id=13372&from=1

Class Period: October 18, 2018 - December 17, 2020

Lead Plaintiff Deadline: March 5, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds' update server had an easily accessible password of ‘solarwinds123'; (3) consequently, SolarWinds' customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants' statements about SolarWinds's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Exxon Mobil Corporation (NYSE:XOM)

CONTACT JAKUBOWITZ ABOUT XOM:
https://claimyourloss.com/securities/exxon-mobil-corporation-loss-submission-form/?id=13372&from=1

Class Period: February 28, 2018 - January 14, 2021

Lead Plaintiff Deadline: March 29, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Exxon forced its employees to use unrealistic assumptions regarding the timelines for well drilling in the Permian Basin; (ii) the foregoing assumptions served to artificially inflate the value of the Company's well operations in the Permian Basin; (iii) the foregoing conduct, when revealed, subjected Exxon to a heightened risk of regulatory investigation and oversight; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Athenex, Inc. (NASDAQ:ATNX)

CONTACT JAKUBOWITZ ABOUT ATNX:
https://claimyourloss.com/securities/athenex-inc-loss-submission-form/?id=13372&from=1

Class Period: August 7, 2019 - February 26, 2021

Lead Plaintiff Deadline: May 3, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) the Company's Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/633765/Lawsuits-Filed-Against-SWI-XOM-and-ATNX--Jakubowitz-Law-Pursues-Shareholders-Claims